0001179110-18-002073.txt : 20180214
0001179110-18-002073.hdr.sgml : 20180214
20180214172709
ACCESSION NUMBER: 0001179110-18-002073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180212
FILED AS OF DATE: 20180214
DATE AS OF CHANGE: 20180214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37359
FILM NUMBER: 18613904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Blueprint Medicines Corp
CENTRAL INDEX KEY: 0001597264
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-374-7580
MAIL ADDRESS:
STREET 1: 45 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
edgar.xml
FORM 4 -
X0306
4
2018-02-12
0
0001597264
Blueprint Medicines Corp
BPMC
0001177082
LYNCH DANIEL
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2018-02-12
4
S
0
1530
77.18
D
202812
D
Common Stock
2018-02-12
4
S
0
2590
75.96
D
200222
D
Common Stock
2018-02-12
4
S
0
5636
75.15
D
194586
D
Common Stock
2018-02-12
4
S
0
3748
74.31
D
190838
D
Common Stock
2018-02-12
4
S
0
3996
73.27
D
186842
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted on December 20, 2016 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.93 to $77.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.66 to $76.64 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.64 to $75.63 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.75 to $74.62 per share.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.67 to $73.58 per share.
/s/ Christopher Frankenfield, Attorney-in-Fact
2018-02-14